<DOC>
	<DOCNO>NCT01750749</DOCNO>
	<brief_summary>Chronic venous leg ulcer ( CVU ) represent medical problem associate significant morbidity , increase work absenteeism earlier retirement consequence disability . This strongly affect patient 's quality life significant economic impact healthcare system . Reports study animal model show treatment bone marrow-derived stem cell beneficial effect heal chronic skin wound . The purpose pilot study determine safety feasibility cell therapy bone marrow derive cell ( BMDC ) complementary heal therapy chronic venous leg ulcer , addition evaluate effectiveness . The knowledge gain pilot study use refine clinical protocol procedure subsequent randomize study . Patients venous legs ulcer meet eligibility criterion provide appropriate write informed consent enrol study participation . Enrolled patient receive Autologous BMDC implantation de venous ulcer conjunction standard care ( SOC ) treatment . During follow , adverse event assess ulcer clinical examination . Effectiveness experimental treatment assess evaluate ulcer healing ( reduction ulcer area ) pain reduction six-month period .</brief_summary>
	<brief_title>Cell Therapy Venous Leg Ulcers Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Leg Ulcer</mesh_term>
	<mesh_term>Varicose Ulcer</mesh_term>
	<criteria>Age 40 75 year Patients primary venous insufficiency Patients venous ulcer area large 2 cm2 , receive SOC treatment previous three month . Ulcers negative bacterial culture polymicrobial flora . Patients decompensated heart failure . Patients low limb edema nonvenous etiology . Patients diagnosis diabetes mellitus . Patients body mass index ( BMI ) â‰¤ 18.5 &gt; 40 .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Venous ulcer</keyword>
	<keyword>Cell therapy</keyword>
</DOC>